IDO and outcomes in ovarian cancer
- PMID: 19822256
- DOI: 10.1016/j.ygyno.2009.09.017
IDO and outcomes in ovarian cancer
Comment on
-
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.Gynecol Oncol. 2009 Nov;115(2):185-92. doi: 10.1016/j.ygyno.2009.07.015. Epub 2009 Aug 8. Gynecol Oncol. 2009. PMID: 19665763
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials